Siyuan Zhou

5.1k citations
177 papers · 3.8k indexed · h-index 35
Topics
Nanoparticle-Based Drug Delivery (19 papers)RNA Interference and Gene Delivery (18 papers)Nanoplatforms for cancer theranostics (15 papers)

In The Last Decade

Siyuan Zhou

172 papers receiving 3.8k citations

Peers

Siyuan Zhou
Comparison fields: 5 of 140
  • Molecular Biology 1.4k
  • Biomaterials 670
  • Biomedical Engineering 651
  • Oncology 321
  • Materials Chemistry 306
Replace Ayman Saleh with:
Ayman Saleh Saudi Arabia
Jingping Liu China
Amit Kumar Dinda India
Hamidreza Pazoki–Toroudi Iran
Chiara Dianzani Italy
Betül Karademir Türkiye
Jianyou Shi China
Daxiong Xiang China
Sun Young Park South Korea
Siyuan Zhou relative to Ayman Saleh Saudi Arabia Ayman Saleh's profile →
Citations per field
00.5×10×15×18×
Ayman Saleh · 1×
Citations per year

Countries citing papers authored by Siyuan Zhou

Since Specialization
Citations

This map shows the geographic impact of Siyuan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siyuan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siyuan Zhou more than expected).

Fields of papers citing papers by Siyuan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siyuan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siyuan Zhou. The network helps show where Siyuan Zhou may publish in the future.

Co-authorship network of co-authors of Siyuan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Siyuan Zhou. A scholar is included among the top collaborators of Siyuan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siyuan Zhou. Siyuan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 6
5 12
6 1
7 14
8 67
9 3
10 19
11 15
12 3
13 5
14 39
15 16
16 10
17 19
18 8
19 2
20
Characteristic immunoloregulation effect of Angelica polysaccharide fraction(AP-3) purified from Angelica sinensis
1

About Siyuan Zhou

Siyuan Zhou is a scholar working on Biomaterials, Geriatrics and Gerontology and Physiology, having authored 177 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (18 papers) and Nanoplatforms for cancer theranostics (15 papers). The work is most often cited by research in Biomaterials (670 citations), Geriatrics and Gerontology (146 citations) and Biochemistry (150 citations). Siyuan Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bang‐Le Zhang, Qibing Mei, Daozhou Liu, Miao Liu, Meng‐Lei Huan, Han Cui, Ying Cheng, Zenghui Teng, Guohua Zhao and Tiehong Yang. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026